ArticleThe international journal of cardiovascular imaging2021
Prediction of risk factors for recurrence of atrial fibrillation in patients with arterial hypertension.
Article in The international journal of cardiovascular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 7 citations in OpenAlex.
- Pre-procedural high serum visfatin and tumor necrosis factor-α might predict recurrent atrial fibrillation after catheter ablation.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2023Article
- Sex differences in the association between blood pressure and atrial fibrillation: A case-control study.Frontiers in cardiovascular medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work aimed to assess the significance of risk factors for atrial fibrillation recurrence and predict the significance of these factors in the development of arterial hypertension in patients. For the first time, the authors performed prognostic analysis of atrial fibrillation recurrence probability taking into account the number and significance of risk factors. The study was conducted in 2018-2019 based on the Cardiovascular Department of Military Hospital 175, Ho Chi Minh City (Vietnam). A total of 200 patients were diagnosed with arterial hypertension of I-III degree, divided into 2 groups: Group 1 (84 patients) without recurrence of atrial fibrillation, Group 2 (116 patients) with recurrences. All patients underwent echocardiographic and veloergometric studies, as well as Holter monitoring. Group 2 consisted of a significantly higher number of overweight patients (p ≤ 0.05) compared to Group 1. Also, more patients with a prolonged period of arterial hypertension (p ≤ 0.05), high blood pressure (p ≤ 0.02), and diabetes mellitus (p ≤ 0.01) were found in Group 1. A history of atrial fibrillation was more typical for Group 2 (p ≤ 0.03). Among risk factors, arterial hypertension of III degree (0.01) and left ventricular myocardial mass index (0.02) had the highest level of significance. Maximum unfavorable prognosis of atrial fibrillation recurrence is released under the action of all three factors. Under one risk factor (arterial hypertension), the degree of risk is quite high (1.4 times), but minimal compared to the other factors. With the fibrillation, the risk of recurrence increases slightly (1.6 times, p ≤ 0.05). The risk of atrial fibrillation recurrence is maximal when all three factors are combined (with atrial dilatation attached), with the risk increasing almost 2-fold (2.2-fold, p ≤ 0.01).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.